Globus Medical, Inc. (GMED) Guidance & Earnings Results

On 2026-08-06 Globus Medical, Inc. raised guidance: "Non-GAAP diluted EPS raised to $4.95-$5.05 from $4.70-$4.80; revenue reaffirmed…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

GMEDGlobus Medical, Inc.Follow GMED — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 10.9B
P/E TTM: 20.9
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Aug 26	Raised	Non-GAAP diluted EPS raised to $4.95-$5.05 from $4.70-$4.80; revenue reaffirmed $3.18B-$3.22B · full year
7 May 26	Raised	FY2026 revenue reaffirmed $3.18-3.22B; non-GAAP EPS raised to $4.70-4.80 from $4.40-4.50 · full year
24 Feb 26	Raised	Non-GAAP EPS guidance raised to $4.40-4.50 from $4.30-4.40 · full year
7 Jan 26	Raised	FY2026 revenue $3.18B-$3.22B, non-GAAP EPS $4.30-$4.40 · full year
6 Nov 25	Raised	Revenue raised to $2.86-$2.90B; EPS raised to $3.75-$3.85 · full year
7 Aug 25	Reaffirmed	FY25 revenue $2.80-2.90B; FY25 non-GAAP diluted EPS $3.00-3.30. · full year

Globus Medical, Inc. — questions

What guidance did Globus Medical, Inc. give?: On 2026-08-06: "Non-GAAP diluted EPS raised to $4.95-$5.05 from $4.70-$4.80; revenue reaffirmed $3.18B-$3.22B"
When does Globus Medical, Inc. report earnings?: Globus Medical, Inc.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from Globus Medical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.